Back
Shake Shack 10K Form
Buy
59
SHAK
Shake Shack
Last Price:
102.75
Seasonality Move:
-0.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-03 | 10Q | SHAK/Shake Shack Quarterly |
2023-08-04 | 10Q | SHAK/Shake Shack Quarterly |
2023-05-05 | 10Q | SHAK/Shake Shack Quarterly |
2022-11-04 | 10Q | SHAK/Shake Shack Quarterly |
2022-08-05 | 10Q | SHAK/Shake Shack Quarterly |
2022-05-06 | 10Q | SHAK/Shake Shack Quarterly |
Receive SHAK News And Ratings
See the #1 stock for the next 7 days that we like better than SHAK
SHAK Financial Statistics
Sales & Book Value
Annual Sales: | $1.09B |
---|---|
Cash Flow: | $20.61M |
Price / Cash Flow: | 259.24 |
Annual Sales: | $11.57 |
Price / Book: | 8.8 |
Profitability
EPS (TTM): | 0.62000 |
---|---|
Net Income (TTM): | $26.56M |
Gross Margin: | $478.24M |
Return on Equity: | 5.77% |
Return on Assets: | 1.66% |
Shake Shack Earnings Forecast
Key Shake Shack Financial Ratios
- The Gross Profit Margin over the past 12 years for SHAK is 43.97%.
- The Selling, General & Administrative Expenses for SHAK have been equal to 19.25% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 8.47% of Operating Income.
- The Net Earning history of SHAK is 1.86% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
Shake Shack Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Hotels, Restaurants & Leisure |
Sector: | Consumer Discretionary |
Current Symbol: | SHAK |
CUSIP: | 819047 |
Website: | shakeshack.com |
Debt
Debt-to-Equity Ratio: | 0.53 |
---|---|
Current Ratio: | 2.06 |
Quick Ratio: | 1.98 |
Price-to-Earnings
Trailing P/E Ratio: | 212.08 |
---|---|
Forward P/E Ratio: | 98.31 |
SHAK Technical Analysis vs Fundamental Analysis
Buy
59
Shake Shack (SHAK)
is a Buy
Is Shake Shack a Buy or a Sell?
-
Shake Shack stock is rated a Buy
The current Shake Shack [SHAK] share price is $101.80. The Score for SHAK is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.